Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Caution evidenceCoverage 3/5 core metricsLatest reported free cash flow was -$22M.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Free cash flow was negative
Latest reported free cash flow was -$22M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2024-12-31.
- No current rule-based risk flags
3 filing-based checks were evaluable.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Asset Management Segment$3.65M100.0%no prior
- Corporate And Other$00.0%no prior
Members sum to the consolidated $3.65M for this period.
- Asset Management Segment-$22.7M100.0%no prior
- Corporate And Other$00.0%no prior
Members sum to the consolidated -$22.7M for this period.
- Investment Advice$3.59M98.4%no prior
- Product And Service Other$58K1.6%no prior
Members sum to the consolidated $3.65M for this period.
- Medical Device Segment$1.37M49.6%no prior
- Asset Management Segment$1.35M48.8%-5.3% yoy
- Corporate And Other$43K1.6%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
Not available for ASST: No stored feature row with a computable metric for this issuer (funds, trusts and 20-F filers are not crawled)..
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 45 changed periods, 30 largest shown| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Equity issued ProceedsFromIssuanceOfCommonStock | fiscal year 2022-12-31 | $976 10-K 2023-03-31 | $755K 10-K 2024-04-02 | +77248.9% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2024-09-30 | $2.26M 10-Q 2024-11-14 | $27.5M 10-Q 2025-11-14 | +1117.5% | first · latest |
| Total liabilities Liabilities | balance at 2024-12-31 | $431K 10-K 2025-03-31 | $4.86M 10-K 2026-03-19 | +1026.7% | first · latest · 5 filings carry it |
| Total assets Assets | balance at 2024-12-31 | $3.22M 10-K 2025-03-31 | $28.2M 10-K 2026-03-19 | +776.4% | first · latest · 5 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2024-12-31 | $2.79M 10-K 2025-03-31 | $23.3M 10-Q 2026-08-10 | +737.7% | first · latest · 7 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2024-03-31 | $1.86M 10-Q 2024-05-15 | $11.3M 10-Q 2025-11-14 | +505.0% | first · latest · 6 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2023-12-31 | $2.92M 10-K 2024-04-02 | $16.1M 10-K 2026-03-19 | +449.5% | first · latest · 9 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2024-09-30 | -$1.32M 10-Q 2024-11-14 | -$7.01M 10-Q 2025-11-14 | -432.9% | first · latest |
| Net income NetIncomeLoss | quarter 2024-09-30 | -$1.32M 10-Q 2024-11-14 | -$6.8M 10-Q 2025-11-14 | -417.1% | first · latest |
| Operating cash flow NetCashProvidedByUsedInOperatingActivities | fiscal year 2024-12-31 | -$4.9M 10-K 2025-03-31 | -$21.6M 10-K 2026-03-19 | -340.7% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2025-03-31 | $4.53M 10-Q 2025-05-15 | $19.6M 10-Q 2026-08-10 | +332.2% | first · latest · 5 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2025-06-30 | $2.68M 10-Q 2025-08-05 | $10.7M 10-Q 2026-08-10 | +299.3% | first · latest · 3 filings carry it |
| Operating cash flow NetCashProvidedByUsedInOperatingActivities | quarter 2025-03-31 | -$1.57M 10-Q 2025-05-15 | -$5.59M 10-Q 2026-05-14 | -255.8% | first · latest |
| Operating income OperatingIncomeLoss | fiscal year 2024-12-31 | -$6.4M 10-K 2025-03-31 | -$22.7M 10-K 2026-03-19 | -253.8% | first · latest |
| Net income NetIncomeLoss | quarter 2024-03-31 | -$1.39M 10-Q 2024-05-15 | -$4.79M 10-Q 2025-11-14 | -245.4% | first · latest · 6 filings carry it |
| Net income NetIncomeLoss | quarter 2024-06-30 | -$1.73M 10-Q 2024-08-14 | -$5.87M 10-Q 2025-11-14 | -239.9% | first · latest · 4 filings carry it |
| Net income NetIncomeLoss | fiscal year 2024-12-31 | -$6.39M 10-K 2025-03-31 | -$21.6M 10-K 2026-03-19 | -237.5% | first · latest |
| Net income NetIncomeLoss | quarter 2025-06-30 | -$2.66M 10-Q 2025-08-05 | -$8.88M 10-Q 2026-08-10 | -233.1% | first · latest · 3 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2024-06-30 | $2.1M 10-Q 2024-08-14 | $5.4M 10-Q 2025-11-14 | +157.4% | first · latest · 4 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2025-03-31 | -$1.66M 10-Q 2025-05-15 | -$4.07M 10-Q 2026-05-14 | -145.8% | first · latest |
| Cash CashAndCashEquivalentsAtCarryingValue | balance at 2024-12-31 | $2.66M 10-Q 2025-05-15 | $6.16M 10-K 2026-03-19 | +131.3% | first · latest · 4 filings carry it |
| Net income NetIncomeLoss | quarter 2025-03-31 | -$1.62M 10-Q 2025-05-15 | -$3.75M 10-Q 2026-08-10 | -130.8% | first · latest · 5 filings carry it |
| Stock-based compensation ShareBasedCompensation | fiscal year 2024-12-31 | $1.21M 10-K 2025-03-31 | $0 10-K 2026-03-19 | -100.0% | first · latest |
| Stock-based compensation ShareBasedCompensation | quarter 2025-03-31 | $253K 10-Q 2025-05-15 | $0 10-Q 2026-05-14 | -100.0% | first · latest |
| Equity issued ProceedsFromIssuanceOfCommonStock | fiscal year 2024-12-31 | $2.39M 10-K 2025-03-31 | $0 10-K 2026-03-19 | -100.0% | first · latest |
| Equity issued ProceedsFromIssuanceOfCommonStock | quarter 2025-03-31 | $3.12M 10-Q 2025-05-15 | $0 10-Q 2026-05-14 | -100.0% | first · latest |
| Diluted shares WeightedAverageNumberOfDilutedSharesOutstanding | quarter 2025-06-30 | 15,591,759 shares 10-Q 2025-08-05 | 2,300,998 shares 10-Q 2026-08-10 | -85.2% | first · latest |
| Basic shares WeightedAverageNumberOfSharesOutstandingBasic | quarter 2025-06-30 | 15,591,759 shares 10-Q 2025-08-05 | 2,300,998 shares 10-Q 2026-08-10 | -85.2% | first · latest |
| Diluted shares WeightedAverageNumberOfDilutedSharesOutstanding | quarter 2025-03-31 | 13,155,432 shares 10-Q 2025-05-15 | 2,275,940 shares 10-Q 2026-05-14 | -82.7% | first · latest |
| Basic shares WeightedAverageNumberOfSharesOutstandingBasic | quarter 2025-03-31 | 13,155,432 shares 10-Q 2025-05-15 | 2,275,940 shares 10-Q 2026-05-14 | -82.7% | first · latest |
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
Not available for ASST yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.